Veeda Lifesciences Partners with Mango Sciences for AI-Driven Clinical Trials

Veeda Lifesciences has announced a partnership with Mango Sciences to integrate AI technology into its clinical trial services, announced in a press release. This collaboration aims to improve the speed, efficiency, and quality of clinical trials by leveraging Mango Sciences' AI-powered Querent™ platform.

The partnership will enable Veeda to automate patient identification and expand its reach across Europe, focusing on enhancing diversity in clinical trials. By utilizing advanced data analytics, the AI-driven platform will streamline processes, improve data management, and ensure higher quality standards through broader representation of non-Caucasian populations.

Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Clinical Research Limited, highlighted that this partnership will transform Veeda into an AI-driven oncology drug development organization. The integration of Large Language Models (LLMs) and Generative-AI into the Querent™ platform is expected to drive operational efficiencies and improve real-world evidence, ultimately identifying the right drug for the right patient.

Veeda's strategic investments, including the acquisition of Health Data Specialists, have strengthened its position as a tech-enabled, AI-driven CRO, providing access to oncology cohorts in India and Europe. This supports Veeda's aim to maintain a competitive edge in the CRO sector while delivering services to pharmaceutical and biopharmaceutical clients globally.